We are live on ! Find out more
BS

Boenning & Scattergood Portfolio holdings

AUM $622M
1-Year Est. Return 8.79%
This Fund
S&P 500
This Quarter Est. Return
+2.2%
1 Year Est. Return
-8.79%
3 Year Est. Return
+34.52%
5 Year Est. Return
10 Year Est. Return
AUM
$342M
AUM Growth
+$8.33M
Cap. Flow
+$16.6M
Cap. Flow %
4.86%
Top 10 Hldgs %
23.28%
Holding
287
New
7
Increased
114
Reduced
83
Closed
18

Top Sells

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$1.85M
2
TGT icon
Target
TGT
+$1.48M
3
DIS icon
Walt Disney
DIS
+$1.23M
4
T icon
AT&T
T
+$1.22M
5
JPM icon
JPMorgan Chase
JPM
+$1.18M

Sector Composition

Rank Sector Weight
1 Healthcare 15.84%
2 Technology 13.8%
3 Financials 10.35%
4 Industrials 10.04%
5 Energy 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$615B
$13.1M 3.83%
94,176
-304
-0.3% -$42.1K
AAPL icon
2
Apple
AAPL
$4.79T
$10.3M 3.01%
208,264
-3,564
-2% -$174K
MSFT icon
3
Microsoft
MSFT
$2.9T
$9.8M 2.86%
73,152
+911
+1% +$116K
XOM icon
4
ExxonMobil
XOM
$640B
$9.41M 2.75%
122,745
-537
-0.4% -$41.6K
PEP icon
5
PepsiCo
PEP
$185B
$7.29M 2.13%
55,625
+232
+0.4% +$29.7K
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.06T
$6.83M 2%
32,049
-246
-0.8% -$50.9K
T icon
7
AT&T
T
$160B
$5.81M 1.7%
229,541
-50,852
-18% -$1.22M
VZ icon
8
Verizon
VZ
$185B
$5.79M 1.69%
101,385
-3,463
-3% -$200K
JPM icon
9
JPMorgan Chase
JPM
$926B
$5.73M 1.67%
51,274
-10,685
-17% -$1.18M
UHT
10
Universal Health Realty Income Trust
UHT
$601M
$5.59M 1.63%
233,786
+228,436
+4,270% +$18.8M
HD icon
11
Home Depot
HD
$330B
$5.5M 1.61%
26,433
-25
-0.1% -$4.99K
ABBV icon
12
AbbVie
ABBV
$448B
$4.64M 1.36%
63,817
+2,349
+4% +$185K
ABT icon
13
Abbott
ABT
$175B
$4.63M 1.35%
55,004
+380
+0.7% +$29.9K
PG icon
14
Procter & Gamble
PG
$347B
$4.5M 1.32%
41,042
-3,261
-7% -$348K
CVS icon
15
CVS Health
CVS
$138B
$4.48M 1.31%
82,194
+6,366
+8% +$343K
CVX icon
16
Chevron
CVX
$384B
$4.48M 1.31%
35,969
+1,320
+4% +$160K
IBM icon
17
IBM
IBM
$193B
$4.15M 1.21%
31,456
+5,154
+20% +$677K
GOOG icon
18
Alphabet (Google) Class C
GOOG
$4.17T
$4.04M 1.18%
74,760
-2,600
-3% -$150K
BDX icon
19
Becton Dickinson
BDX
$42.2B
$3.95M 1.15%
16,072
-273
-2% -$63.4K
HON icon
20
Honeywell
HON
$73.8B
$3.61M 1.05%
21,936
+531
+2% +$84.5K
PFE icon
21
Pfizer
PFE
$141B
$3.47M 1.02%
84,518
+1,156
+1% +$45.9K
EPD icon
22
Enterprise Products Partners
EPD
$84.1B
$3.46M 1.01%
119,881
+2,934
+3% +$84.5K
MCD icon
23
McDonald's
MCD
$187B
$3.43M 1%
16,498
+1,216
+8% +$241K
WFC icon
24
Wells Fargo
WFC
$262B
$3.38M 0.99%
71,529
+24,238
+51% +$1.13M
EMR icon
25
Emerson Electric
EMR
$78.2B
$3.27M 0.96%
48,998
+185
+0.4% +$12.4K

Similar funds

Boenning & Scattergood's Q2 2019 Portfolio in Review

As of Q2 2019, Boenning & Scattergood held 287 positions worth $342M, up 2.5% from $334M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Boenning & Scattergood deployed $16.6M of net new capital in Q2 2019, opening 7 new positions and adding to 114 existing holdings. Its largest new stake was Nuveen AMT-Free Quality Municipal Income Fund: 63,280 shares worth $874K.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $1.85M trimmed.

  • Boenning & Scattergood's largest Q2 2019 buy was Nuveen AMT-Free Quality Municipal Income Fund: 63,280 shares worth $874K.
  • Boenning & Scattergood added most to Universal Health Realty Income Trust in Q2 2019, an estimated $18.8M increase.
  • Boenning & Scattergood's biggest Q2 2019 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $1.85M.
  • Boenning & Scattergood fully exited Target in Q2 2019, selling an estimated $1.48M.
  • Boenning & Scattergood's ten largest holdings make up 23% of its $342M portfolio in Q2 2019.
  • Boenning & Scattergood opened 7 new positions and closed 18 in Q2 2019.
  • Boenning & Scattergood's portfolio value rose 2.5% quarter-over-quarter to $342M.

Based on Boenning & Scattergood's 13F filing for Q2 2019, filed 15 Jul 2019.